JBS (JBS) Stock Price & Analysis
JBS (JBS) rose 1.98% to USD 11.85 as of June 10, 2026 at 00:27 UTC, according to Nexqual real-time market data.
JBS last closed at USD 11.62; the session ranged USD 11.68–11.99 on volume of 5,476,658 shares. Market capitalization is $12.69B, with a 52-week range of USD 11.49–18.65 (NYQ). Source: Nexqual, June 10, 2026 at 00:27 UTC.
Key Statistics (as of June 10, 2026 at 00:27 UTC)
| Price | USD 11.85 |
|---|---|
| Change | ▲ 1.98% (up) |
| Previous Close | USD 11.62 |
| Open | USD 11.74 |
| Day Range | USD 11.68 – 11.99 |
| 52-Week Range | USD 11.49 – 18.65 |
| Volume | 5,476,658 shares |
| Market Cap | $12.69B |
| Exchange | NYQ |
Technical Analysis (JBS)
Nexqual's technical model rates JBS "SELL" based on 2 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 00:27 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 28.47 (oversold) |
| vs SMA50 | Below (USD 15.44) |
| MACD | -0.99 (negative) |
Analyst Ratings (JBS)
Wall Street analysts rate JBS "Strong Buy" based on 15 analysts, with a mean price target of USD 19.04 (range USD 16.14–21.37), per Nexqual as of June 10, 2026 at 00:27 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 15 |
| Mean Target | USD 19.04 |
| High Target | USD 21.37 |
| Low Target | USD 16.14 |
| Buy / Hold / Sell | 14 / 1 / 0 |
Earnings (JBS)
| Next Earnings Date | 2026-08-10 |
|---|---|
| EPS Estimate | USD 1.71 |
| Revenue Estimate | $113.50B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-12-31 | USD 3.07 vs est 2.25 ▲ beat |
| 2025-09-30 | USD 2.87 vs est 2.74 ▲ beat |
| 2025-06-30 | USD 1.54 vs est 2.63 ▼ miss |
Source: Nexqual, June 10, 2026 at 00:27 UTC.
Financials & Fundamentals (JBS)
| Total Revenue | $88.27B |
|---|---|
| Revenue Growth (YoY) | +10.70% |
| Gross Margin | +12.46% |
| Operating Margin | +2.37% |
| Profit Margin | +1.98% |
| ROE | +22.10% |
| Debt / Equity | 268.23 |
| Current Ratio | 1.5 |
| Total Cash | $3.29B |
| Total Debt | $24.30B |
| Free Cash Flow | $409.56M |
Source: Nexqual, June 10, 2026 at 00:27 UTC.
Financial Health Score (JBS)
Nexqual rates JBS's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 00:27 UTC.
| Growth | Solid — Revenue +8% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 12%, operating 2% |
| Balance Sheet | Weak — $3.29B cash vs $24.3B debt |
| Cash Flow | Mixed — FCF $410M, slim 0.1% margin |
| Efficiency | Strong — ROE 22%, ROA 5.6% |
Ownership (JBS)
| Insider Ownership | +55.07% |
|---|---|
| Institutional Ownership | +22.39% |
| Shares Outstanding | 776.03M |
| Float | 327.59M |
| Short % of Float | +10.22% |
Source: Nexqual, June 10, 2026 at 00:27 UTC.
Leadership (JBS)
JBS is led by Gilberto Tomazoni (age 66), Global Chief Executive Officer & Executive Director, per Nexqual as of June 10, 2026 at 00:27 UTC.
| Global Chief Executive Officer & Executive Director | Gilberto Tomazoni (age 66) |
|---|---|
| Global CFO & Investor Relations Officer | Guilherme Perboyre Cavalcanti (age 57) |
| Managing & Controlling Officer, Director of Administrative & Control and Member of the Exe. Board | Eliseo Santiago Perez Fernandez (age 60) |
| Head of HR in North America & Global HR Director | Juriana Sperandio Domingues |
| President of Swift | Vincent Trius (age 66) |
Major Backers & Investors (JBS)
Notable institutional backers of JBS include Bndes Participacoes S.A., Davis Selected Advisers, Arrowstreet Capital, Limited Partnership, according to Nexqual as of June 10, 2026 at 00:27 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Bndes Participacoes S.A. | 25.68% |
| Davis Selected Advisers | 3.38% |
| Arrowstreet Capital, Limited Partnership | 0.99% |
| Ameriprise Financial, Inc. | 0.86% |
| Shaw D.E. & Co., Inc. | 0.82% |
| Alberta Investment Management Corp | 0.65% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 5.4% |
| State Street | 0.79% |
| Deutsche Bank AG | 0.68% |
| Columbia Threadneedle | 0.66% |
Source: Nexqual, June 10, 2026 at 00:27 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AMRZ | Amrize Ltd | USD 52.69 | ▼ 1.66% |
| QXO | QXO, Inc. | USD 16.4 | ▲ 4.06% |
| PRMB | Primo Brands Corporation | USD 23.38 | ▲ 1.87% |
| SFD | Smithfield Foods, Inc. | USD 26.67 | ▼ 0.74% |
| CSAN | Cosan S.A. | USD 2.69 | ▼ 3.58% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:27 UTC. This page is informational and not investment advice.